Randomized trial of technology-assisted self-monitoring of blood glucose by low-income seniors: improved glycemic control in type 2 diabetes mellitus
| Autor: | Paul E. Knudson, Raymond Fleming, Edith Burns, Jeff Whittle, Howard Leventhal, Jason C. Levine, Steve Flax |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
medicine.medical_specialty 030209 endocrinology & metabolism Type 2 diabetes law.invention 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Randomized controlled trial law Surveys and Questionnaires Blood Glucose Self-Monitoring Humans Medicine 030212 general & internal medicine Poverty General Psychology Aged Glycemic Glycated Hemoglobin Blood glucose monitoring medicine.diagnostic_test business.industry Type 2 Diabetes Mellitus medicine.disease Self Care Psychiatry and Mental health Diabetes Mellitus Type 2 chemistry Physical therapy Self-monitoring Female Glycated hemoglobin business Software |
| Zdroj: | Journal of Behavioral Medicine. 39:1001-1008 |
| ISSN: | 1573-3521 0160-7715 |
| DOI: | 10.1007/s10865-016-9763-5 |
| Popis: | Self-monitoring of blood glucose (SMBG) has been recommended for people with type 2 diabetes mellitus. This trial tested an automated self-management monitor (ASMM) that reminds patients to perform SMBG, provides feedback on results of SMBG, and action tips for improved self-management. This delayed-start trial randomized participants to using the ASMM immediately (IG), or following a delay of 6 months (DG). Glycated hemoglobin (HgbA1c) level and survey data was collected at home visits every 3 months. 44 diabetic men and women, mean age 70, completed the 12-month trial. Baseline HgbA1c was 8.1 % ± 1.0, dropping to 7.3 ± 1.0 by 9 months, with a 3-month lag in the DG (F = 3.56, p = 0.004). Decrease in HgbA1c was significantly correlated to increased frequency of SMBG, R = 0.588, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|